Life Scientist > Molecular Biology

OGT SureSeq Myeloid Plus panel

01 November, 2022

OGT, a Sysmex Group Company, has launched the SureSeq Myeloid Plus panel to detect aberrations in genes implicated in a variety of myeloid disorders.


Finnish study finds men age faster than women

18 October, 2022

Researchers found that men are biologically older than women, with the observed sex difference partially (but not entirely) explained by men's more frequent smoking and larger body size.


Illumina NovaSeq X Series sequencers

11 October, 2022

Illumina has launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus) of production-scale sequencers, designed to enable faster, more powerful and more sustainable sequencing for genome medicine applications.


It is time to start the renaissance of aptamers

06 October, 2022 by Peter Davis

Macugen was the first RNA biotherapeutic approved by the US FDA in 2004, but did you know this is a pegylated RNA-modified aptamer?


CRISPR used to mimic disease, advancing cancer research

04 October, 2022

The technology can activate any gene — including those that have been silenced — allowing new drug targets and causes of drug resistance to be further explored.


DNA transfer to avoid mito inheritance appears safe

05 September, 2022

Transferring the nuclear genome from one egg into the cytoplasm of a donor egg can enable women carrying mutations in their mitochondrial DNA to have healthy babies.


We inherit more epigenetic info than we thought

26 August, 2022

Epigenetic information, which sits on top of DNA and is normally reset between generations, is more frequently carried from mother to offspring than previously thought.


Revealing the genetic architecture underlying substance abuse

22 August, 2022

The genes underlying cigarette smoking are linked to the perception of pain and response to food, as well as the abuse of drugs such as cocaine.


Uni Melbourne and Colossal plan to bring back Tasmanian tiger

19 August, 2022

A University of Melbourne research lab is partnering with genetic engineering company Colossal Biosciences to bring the thylacine back from extinction.


QIAGEN QIAseq UPXome RNA Library Kit

16 August, 2022

QIAGEN's QIAseq UPXome RNA Library Kit, specifically designed for ultralow-input samples, supports labs interested in 3′ RNA sequencing as well as complete transcriptome RNA sequencing.


Warning: CRISPR therapeutics can damage the genome

12 August, 2022

Investigating the impact of CRISPR technology on T cells, researchers detected a significant loss of genetic material in some treated cells.


QIAGEN QIAseq Targeted DNA Pro Panels

12 August, 2022

QIAGEN says its QIAseq Targeted DNA Pro Panels are based on a chemistry that halves to six hours the time researchers need for library preparation of DNA samples.


Decades in the making: RNA's importance to Australia

10 August, 2022 by Peter Davis

Professor Pall (Palli) Thordarson, an award-winning researcher, is set to kickstart RNA capabilities in NSW and finally launch our genetic medicine ecosystem.


Victorian Govt invests in mRNA Innovation Hub

09 August, 2022

The Victorian mRNA Innovation Hub will work to develop next-generation mRNA vaccines and therapeutics to treat a range of diseases.


Protein improves metabolism of insulin-dependent diabetics

01 August, 2022

Scientists have identified a protein called S100A9 that regulates blood glucose, lipids and ketones, without the side effects of insulin.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd